Latest papers

Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.

Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.

Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.

[Effects of fosinopril on proliferation and secretion of extracellular matrix of rat glomerular mesangial cell].

Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty.

Primary hyperaldosteronism in a patient with end-stage renal disease.

Fosinopril H(2)-receptor antagonists interaction studies by derivative spectroscopy.

[Comparative evaluation of the influence of sulfhydryl and phosphate ACE inhibitors on thrombocyte aggregation in patients suffering from atrerial hypertension with metabolic syndrome].

Cardiac treatment in neuro-muscular diseases.

[Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril].

Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.

Clinical study on effect of Garlicin in stabilizing the carotid artery atherosclerotic plaque in patients with primary hypertension and coronary artery disease.

Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex.

Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.

Racial differences are seen in blood pressure response to fosinopril in hypertensive children.

Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome.

Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center.

Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.

The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.